NCT00781404COMPLETEDanonymous

Myocardial Protection During reperfusión in Patients With Acute Coronary Syndrome With ST Segment Elevation Submitted to Primary Angioplasty: Effect of Intracoronary Adenosine on Infarct Size and Ventricular Remodeling.

Sponsor

Source record

David Garcia-Dorado

Phase

Source record

PHASE3

Modality

AI-normalized

small molecule

Target

AI-normalized

Adenosine

Indication / condition

AI-normalized

Acute Myocardial Infarction

Intervention

Source record

Adenosine

Related intelligence directories

Indication directory: Acute Myocardial Infarction Modality directory: small molecule Target directory: Adenosine

Source & freshness

Source record

NCT ID

NCT00781404

Original source

ClinicalTrials.gov

Source last updated

Feb 18, 2013

Ingested at

Jun 18, 2026

Internal sync

Jun 18, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record

View original source fields

NCT ID

NCT00781404

Title

Myocardial Protection During reperfusión in Patients With Acute Coronary Syndrome With ST Segment Elevation Submitted to Primary Angioplasty: Effect of Intracoronary Adenosine on Infarct Size and Ventricular Remodeling.

Sponsor

David Garcia-Dorado

Status

COMPLETED

Phase

PHASE3

Condition raw

Acute Myocardial Infarction

Condition normalized

Acute Myocardial Infarction

Modality raw

small molecule

Modality normalized

small molecule

Target raw

Adenosine

Target normalized

Adenosine

Interventions

Adenosine

Public preview

Source record

OBJECTIVE: to evaluate the safety and efficacy of a brief intracoronary infusion of ADO applied at the time of reperfusion to limit infarct size and LV remodelling in patients with ACSST submitted to primary ACTP.

DESIGN: Multicentric, prospective, randomised, parallel, placebo-controlled double-blind study.

PATIENTS: 200 patients older than 18 with ACSST and without prior myocardial infarction receiving primary PTCA within 6 hours after symptom onset.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections

Patent/IP landscape with verified records when available

Board-ready PDF export with source provenance

Save to folders and synthesize multiple assets in premium workspace

Create account

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Myocardial Protection During reperfusión in Patients With Acute Coronary Syndrome With ST Segment Elevation Submitted to Primary Angioplasty: Effect of Intracoronary Adenosine on Infarct Size and Ventricular Remodeling.

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 18, 2026

NCT ID

NCT00781404

Status

COMPLETED

Phase

PHASE3

Sponsor

David Garcia-Dorado

Executive brief

Investment-Ready Snapshot

OBJECTIVE: to evaluate the safety and efficacy of a brief intracoronary infusion of ADO applied at the time of reperfusion to limit infarct size and LV remodelling in patients with ACSST submitted to primary ACTP. DESIGN: Multicentric, prospective, randomised, parallel, placebo-controlled double-blind study. PATIENTS: 200 patients older than 18 with ACSST and without prior myocardial infarction receiving primary PTCA within 6 hours after symptom onset.

Source & freshness

Provenance

SourceClinicalTrials.gov

Source updatedFeb 18, 2013

Internal syncJun 18, 2026

Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT00781404

Indication

Acute Myocardial Infarction

Modality

small molecule

Target

Adenosine

Intervention

Adenosine

Source record